A prospective cohort of 412 patients in a coronary care unit found that Cystatin C values > 2.86 mg/L on admission were associated with a nine-fold increase in AKI risk, as well as lower survival rates and higher readmission rates [28]. This evidence concerns the gene CST3 and acute kidney injury.